BRISTOL-MYERS SQUIBB COMPANY
Updated 30 days ago
ABECMA is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the ABECMA REMS...
ABECMA® is a CAR T cell therapy for adult patients with Relapsed/Refractory Multiple Myeloma (RRMM). See Safety Info and Boxed WARNINGS..
Associated domains: car-t-for-relapsed-b-cell-lymphoma.com, choiceinmm.com, empliciti-10.com, emplicitiash.com, emplicitiglider.com, emplicitiinfo.com, emplicitinow.com, emplicitiresources.com, emplicitirx.com, firsttrialsubanalysis.com, hcp-rrmm-treatment-option.com, hcp-rrmm-treatment.com, lenalidomiderems.com, multiplemyelomaoption.com, pomalystrems.com, revlimidhcp.com, revlimidrems.com, thalomidrems.com, tryempliciti.com